lunes, 16 de agosto de 2021

A role for interleukin-1 receptor antagonism in severe COVID-19? - The Lancet Rheumatology

A role for interleukin-1 receptor antagonism in severe COVID-19? - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario